Product Code: RP-ID-10008250 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10008250
Market Overview:
Global Fluoroscopy Equipment Market Size, Growth, Opportunity and Forecast
"The global fluoroscopy equipment/system market in 2021 is estimated to be ~USD 6 billion, and it is expected to grow at a compound annual growth rate of ~4% during the forecast period 2022-2030. The main driving force for this market is the increasing number of interventional radiology procedures that require real-time imaging, such as fluoroscopy. According to a study published on NCBI, the use of CT fluoroscopy in interventional radiology procedures significantly reduces the procedure time and radiation dose, as well as the risks associated with radiation, compared with conventional CT guided procedures. The aforementioned benefits may increase the adoption of these devices in the next few years.
The device is often used in various interventional radiology operations, especially for the treatment of varicose veins, peripheral artery disease (PAD), pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysm and other common diseases. This continued use is expected to promote the future growth potential of the fluoroscopy system market.
In addition, the increase in the number of orthopedic surgery and angiography due to sports injuries and the increase in the base of the elderly population are considered to be important factors affecting rendering. Because portable fluoroscopes can perform effective real-time injury assessments for athletes, they are becoming more and more popular in emergency facilities and on-site. The emergence of fluoroscopes in sports medicine is also expected to be the result of related benefits such as high cost-effectiveness and portability.
Technological advancements, such as integration with image intensifiers such as flat screen detectors (FPD), rotational angiography, and computed tomography. The combined use of CT imaging and thallium-doped cesium iodide with magnifying fluoroscopes is expected to further accelerate market growth in the next few years. Therefore, advantages such as high image quality, reduced radiation risk, time and workflow efficiency, dose reduction, minimal invasiveness and trauma, and increased visibility during surgery are expected to drive doctors’ preferences and thereby increase doctors’ preferences. forecast. Period.
PRODUCT INFORMATION:
In 2020, the largest share of fluoroscopy equipment in the product market segment exceeded 70%. The dominant share of this market segment is believed to be the result of use in a wide range of procedures, such as guided biopsy through imaging, angiography, and angiography. record. In addition, the increased use of fluoroscopes in previously undeveloped applications, such as quality assurance and non-destructive testing of medical equipment, is expected to become a key factor for large-scale participation in this field.
Sensitivity, X-ray recording capabilities, optical magnification, and lower levels of scattered radiation are the main reasons. In addition, the impact of the fluoroscopy device receptor table is relatively small, so the clarity, stability and real-time tracking of the image are higher. As we all know, the laboratory provides automatic logic to control image quality and dose rate.
The above factors are expected to become some of the key factors driving demand over the years. The integration of fluoroscopes with advanced image intensifiers and spectral shaping filter technologies is believed to optimize image-guided surgical procedures, thereby increasing their adoption by radiologists and surgeons. In addition, it is speculated that the emergence of digital fluoroscopy systems used in gastroenterology is the reason why it became the largest product segment in 2016.
END USE INSIGHTS:
Hospitals accounted for the largest share of the end-use market segment in 2020, which can be attributed to a large number of patient responses and frequent readmissions. Supportive infrastructure facilitates successful surgical procedures, requires the use of C-arms and fluoroscopy equipment, resulting in a higher proportion of hospitals as a key growth factor.
For example, an initiative of the US FDA to reduce and optimize the radiation exposure of medical images has led to better treatment of various diseases and higher hospital safety. Together, these factors have resulted in hospitals occupying a larger share of the end-use market segment.
Public and private healthcare organizations are increasingly inclined to promote advanced radiography and imaging instruments to bring better results to patients, which is one of the key factors for an important part of this market segment.
In addition, hospitals are increasingly using fully automated systems that can detect diseases at an early stage. It is expected that the diagnosis center will grow steadily throughout the prophase period. This can be attributed to the increasing importance of anatomical visualization in emergency medicine. When used in combination with other diagnostic and treatment methods (such as contrast agents), fluoroscopy helps early detection. For example, during cardiac catheterization, fluoroscopy equipment is used as an aid to assess blood flow and detect if there is an arterial blockage.
REGIONAL INFORMATION:
North America accounted for the largest share of this equipment market in 2020. The number of strategic cooperation aimed at developing a new generation of products is the same, occupying a considerable share. A strict regulatory and reimbursement framework designed to ensure patient safety and high diagnostic standards is expected to drive demand in the region. A large part of the North American record is attributable to the growing base of obese people.
The increase in the number of minimally invasive procedures has resulted in a considerable proportion. In recent years, the increased use of these devices in the region is an effective auxiliary means that can provide better guidance for minimally invasive surgery.
The Asia-Pacific region is expected to grow at a profitable rate during the forecast period. Emerging economies in the region, such as India and China, are experiencing strong economic growth. The increasing prevalence of diseases and improved infrastructure standards have stimulated the demand for advanced diagnostics in the region.
INFORMATION ABOUT THE MARKET SHARE OF THE PERSPECTIVE SYSTEM:
The global market is inherently highly competitive. The feature of this game is that well-known companies such as GE Healthcare, Philips Healthcare and Siemens Healthineers have implemented sustainable development strategies, and these companies represent their dominant market shares. These companies focus on various strategies such as geographic expansion, new product development plans, and mergers and acquisitions.
In August 2015, GE Healthcare and Temple University Medical System signed a 7-year cooperation agreement to expand radiology-based services. The initiative also aims to address challenges related to market competition, cost control, patient outcomes, and medical imaging reimbursement frameworks.
MARKET SEGMENTS COVERED BY THE REPORT:
This report predicts revenue growth at the global, regional, and country levels, and analyzes industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth Research has segmented the global fluoroscopy system market based on products, applications, end-uses, and regions:
Product Outlook (Revenue, USD million, 2022-2030) fluoroscopy equipment C-arm micro-arm C Full-size C-arm application insight (revenue, million dollars, 2022-2030) orthopedics, cardiovascular pain and trauma management, neurology, gastrointestinal urology, general surgery, other end-use perspectives (revenue, million dollars, 2022-2030) hospital Diagnostic Center Specialist Clinic. "
1. Siemens AG
2. GE Healthcare (A Subsidiary of General Electric Company)
3. Koninklijke Philips N.V.
4. Shimadzu Corporation
5. Ziehm Imaging GmbH
6. Toshiba Medical Systems Corporation (Acquired By Canon, Inc.)
7. Hitachi, Ltd.
8. Carestream Health, Inc. (A Subsidiary of Onex Corporation)
9. Hologic, Inc.
10. Lepu Medical Technology Co., Ltd.
11. Agfa-Gevaert Group
12. Adani Systems, Inc.
Related Reports
Proof of Quality & Reliability
